Ambrosia Systems Inc. provides AI-powered platforms and wearable technology for real-time metabolic and glucose monitoring. Their solutions empower individuals and healthcare providers to manage diabetes and wellness through actionable health data.
Ambrosia Systems Inc. is a health technology company that develops hardware and software platforms for real-time health and metabolic monitoring. Their product portfolio includes the NightRider BluCon, a device that converts sensors like the Abbott FreeStyle Libre into real-time continuous glucose monitors (CGM), as well as the LinkBluCon and FollowBluCon mobile applications. More recently, the company has introduced the RIZZ smart ring, a non-invasive wearable designed to track glucose, sleep, stress, heart health, and physical activity through an integrated AI-powered platform. By combining sensor data with AI/ML modules, the company provides tools aimed at metabolic wellness and diabetes management.
These technologies are designed to empower individuals, healthcare providers, and diabetes educators by providing actionable, consolidated health data in a unified dashboard. For partners and businesses, Ambrosia offers a B2B platform that enables the rapid launch of diabetes and weight management services without the need for extensive in-house research and development. The platform aims to bridge the gap between patients and providers, facilitating remote coordination, proactive care plans, and behavior change. Founded in 2016 and headquartered in San Francisco, the company focuses on scaling its innovative monitoring solutions to a global market to support personalized metabolic health and performance tracking.